Navigation Links
Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis
Date:11/7/2007

golimumab 100 mg, respectively, achieved PASI 75 at week 14, compared with 3 percent of patients receiving placebo (P < 0.001). At week 24, PASI 75 responses improved to 56 percent (golimumab 50 mg) and 66 percent (golimumab 100 mg), compared with 1 percent of placebo patients (P < 0.001). In additional analyses, patients receiving golimumab 50 mg and golimumab 100 also experienced improvements in nail psoriasis as measured by NAPSI and these improvements were sustained over time.

"These Phase 3 data show that once monthly subcutaneous administrations of golimumab 50 mg and golimumab 100 mg significantly improved articular and psoriatic manifestations in patients with psoriatic arthritis," said Jerome A. Boscia, MD, senior vice president, Clinical Research and Development, Centocor, Inc. "We are encouraged by these results and believe golimumab holds great promise as a new anti-TNF-alpha therapy for physicians and patients in need of additional therapeutic options."

Disease Activity and Physical Function Improvements

The majority of golimumab-treated patients in the study were classified as good or moderate responders as measured by the Disease Activity Score 28 (DAS28), which measures tender and swollen joints and overall disease activity including measurement of serum C-reactive protein (CRP) levels. After 14 weeks of treatment, 66 percent of patients receiving golimumab 50 mg were DAS28 responders, as were 67 percent of patients receiving the 100 mg dose, compared with 24 percent of patients receiving placebo (P < 0.001). At week 24, 64 percent and 78 percent of patients receiving golimumab 50 mg and 100 mg, respectively, were DAS28 responders, compared with 24 percent of patients receiving placebo (P < 0.001).

Patients receiving golimumab in the study also experienced significant improvements in physical function, as measured by the Health Assessment Questionnaire (HAQ). At week 14, patients receiving golimumab 50 mg experienced a mean i
'/>"/>

SOURCE Centocor Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... IRVINE, Calif. , July 28, ... a leader in lifestyle healthcare and ... today that it has acquired Physician Recommended Nutriceuticals ... specialty omega-3s, and related products for ... in Plymouth Meeting, PA, in a transaction worth ...
(Date:7/28/2014)... -- ResMed (NYSE: RMD ), an innovator and ... breathing and other chronic respiratory conditions, has won a ... Taiwanese medical device manufacturer APEX Medical Corp. (APEX), prohibiting ... and 220 masks.  The judgment was entered by the ... is appealable, and applies throughout Germany.  ...
(Date:7/28/2014)... , July 28, 2014   Cardioxyl Pharmaceuticals, Inc. ... trial demonstrating that CXL-1427, a novel potential treatment for ... healthy volunteers. The company has now initiated dosing of ... IIa clinical trial designed to further evaluate the drug,s ... The Phase I clinical trial evaluated the ...
Breaking Medicine Technology:ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 2ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 3ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2
... IRIDEX Corporation (Nasdaq: IRIX ) today announced the receipt of an ... No. 7,766,904, "Adjustable Laser Probe For Use In Vitreoretinal Surgery." This patent ... product line, collectively identified and sold as Adjustable and Intuitive EndoProbe® laser ... The Adjustable ...
... Denmark , July 29 AdvanDx today ... a fast, 90 minutes protocol for its Yeast Traffic ... PNA FISH turn-around time from the original 2.5 hours ... 90 minutes to 30 minutes.  Clinical validation studies performed ...
Cached Medicine Technology:IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery 2IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery 3AdvanDx Receives FDA 510(k) Clearance for 90 Minutes Protocol for Yeast Traffic Light® PNA FISH® 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes Protocol for Yeast Traffic Light® PNA FISH® 3AdvanDx Receives FDA 510(k) Clearance for 90 Minutes Protocol for Yeast Traffic Light® PNA FISH® 4
(Date:7/29/2014)... Riverdale Urgent Care is making community service ... presence at local events, partnerships and other initiatives, the ... a medical service for the Riverdale neighborhood. , ... of Riverdale RiverFest and South Riverdale Street Fair. Riverdale ... musicians and entertainers, arts and crafts, boat rides and ...
(Date:7/29/2014)... 29, 2014 The Cottages Investment ... Cottages at MeadowLands Memory Care, to break ground July ... suffering from memory loss and forms of dementia, Wade ... the development of Oconto Fall’s first assisted living facility ... of The Cottages Investment Group, LLC will license the ...
(Date:7/29/2014)... NY (PRWEB) July 29, 2014 In today’s ... increasingly difficult to get. Snoring and sleep apnea (a medical ... robs people and their bed partners of the rest they ... 45% of the population snores and 20 million people in ... 10% have been diagnosed and treated; and of those treated, ...
(Date:7/29/2014)... Creek, MI (PRWEB) July 29, 2014 ... program that gets clients off to a great start and ... in, was a proud sponsor of the National Cherry Festival ... MI. , The concert, which was co-sponsored by Miller Lite ... Soul take to the Pepsi Bay Side Music Stage presented ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Ticketability.com has reduced ... have already been selling at lower prices on the secure ... receive a further discount on tickets that are priced lower ... selection of tickets available at Ticketability.com. , Theatergoers know that ... eager to find Phantom of the Opera tickets for sale ...
Breaking Medicine News(10 mins):Health News:Riverdale Urgent Care of the Bronx, NY Puts a Face Back on Medicine 2Health News:Riverdale Urgent Care of the Bronx, NY Puts a Face Back on Medicine 3Health News:The Cottages Investment Group Announces Third Development Project, The Cottages at MeadowLands Memory Care, Oconto Falls 2Health News:The Cottages Investment Group Announces Third Development Project, The Cottages at MeadowLands Memory Care, Oconto Falls 3Health News:The Cottages Investment Group Announces Third Development Project, The Cottages at MeadowLands Memory Care, Oconto Falls 4Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:A Forever Recovery Sponsors National Cherry Festival Kickoff Concert Featuring Collective Soul on July 5 in Traverse City, MI 2Health News:Phantom of the Opera Tickets for Sale: Ticketability.com Delights Customers with Phantom of the Opera Theatre Tickets While Seats Last 2
... body's own ability to get rid of warts, a researchers at ... the needs. In a previous trial, they showed how a ... participants.// The new treatment is a form of immunotherapy - that ... its own defences. ,Warts are caused by a viral ...
... suffering from depression in a primary care visit was ... the doctor, he or she may carry out routine checks ... some experts it is too complicated to screen for depression ... University in USh have analysed all the data relating to ...
... children can get up to almost one-half of their whole ... snacks can have a significant impact on their health.// ... Center felt that, they get the nutrients, they get the ... Recent studies have shown that snacking is growing among US ...
... stem cells develop a relatively small number of mutations which ... embryonic stem cells were actually more genetically stable than some ... and a co-author of the study, everybody has assumed that ... that it is actually lower than what you find in ...
... of stem cells has an outstanding nature. Initially, the mouse ... repair of damaged lung tissue. The potential of stem cells ... cells - is now well established.// Researchers at the Imperial ... of lung cells from stem cells in mice. ...
... service providers, are volunteering to help store the DNA ... order to prevent disease in their descendants .The DNA ... predisposed to conditions such as breast or colon cancer. ... Analysis Inc., the genetic material could also be used ...
Cached Medicine News:Health News:Healthy snacks improve nutrition of kids 2Health News:Stem Cells Have Few Mutations 2Health News:DNA of deceased ones stored in Funeral Homes 2
Convenience, Protection, Comfort and Security -- FirstChoice pouches are your product of choice if you are looking for the convenience of a one-piece pouch that is either cut-to-fit or pre-cut to you...
Built-in convexity means added security and skin protection for recessed, retracted and flush stomas...pre-cut openings. Security and confidence achieved by the internal No-Flowback Valves and soft d...
... the skin over extended wearing time ... is the barrier of choice for ... benefit of it being discreet in ... and confidence assured with internal non-reflux ...
Inquire...
Medicine Products: